Reuters logo
BRIEF-Clarus Therapeutics ‍announced re-submission of new drug application for Jatenzo
June 26, 2017 / 12:40 PM / 5 months ago

BRIEF-Clarus Therapeutics ‍announced re-submission of new drug application for Jatenzo

June 26 (Reuters) - Clarus Therapeutics:

* Clarus Therapeutics - ‍Announced re-submission of new drug application (NDA) for Jatenzo Source text for Eikon:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below